These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 37232341)
1. Inhibition of Wnt/β-catenin pathway overcomes therapeutic resistance to abiraterone in castration-resistant prostate cancer. Atawia IM; Kushwaha PP; Verma S; Lin S; Shankar E; Abdel-Gawad O; Gupta S Mol Carcinog; 2023 Sep; 62(9):1312-1324. PubMed ID: 37232341 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the Wnt/β-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer. Zhang Z; Cheng L; Li J; Farah E; Atallah NM; Pascuzzi PE; Gupta S; Liu X Cancer Res; 2018 Jun; 78(12):3147-3162. PubMed ID: 29700003 [TBL] [Abstract][Full Text] [Related]
3. Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer. Patel R; Brzezinska EA; Repiscak P; Ahmad I; Mui E; Gao M; Blomme A; Harle V; Tan EH; Malviya G; Mrowinska A; Loveridge CJ; Rushworth LK; Edwards J; Ntala C; Nixon C; Hedley A; Mackay G; Tardito S; Sansom OJ; Leung HY Cancer Res; 2020 Feb; 80(3):576-590. PubMed ID: 31719098 [TBL] [Abstract][Full Text] [Related]
4. Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer. Liu C; Armstrong C; Zhu Y; Lou W; Gao AC Oncotarget; 2016 May; 7(22):32210-20. PubMed ID: 27049719 [TBL] [Abstract][Full Text] [Related]
5. Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling. Moll JM; Hofland J; Teubel WJ; de Ridder CMA; Taylor AE; Graeser R; Arlt W; Jenster GW; van Weerden WM Prostate; 2022 Apr; 82(5):505-516. PubMed ID: 35037287 [TBL] [Abstract][Full Text] [Related]
6. A bypass mechanism of abiraterone-resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling. Moll JM; Kumagai J; van Royen ME; Teubel WJ; van Soest RJ; French PJ; Homma Y; Jenster G; de Wit R; van Weerden WM Prostate; 2019 Jun; 79(9):937-948. PubMed ID: 31017696 [TBL] [Abstract][Full Text] [Related]
7. Interplay Between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer. Khurana N; Sikka SC Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31027362 [TBL] [Abstract][Full Text] [Related]
8. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer. Martin SK; Kyprianou N Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899 [TBL] [Abstract][Full Text] [Related]
9. Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate. Stuopelyte K; Sabaliauskaite R; Bakavicius A; Haflidadóttir BS; Visakorpi T; Väänänen RM; Patel C; Danila DC; Lilja H; Lazutka JR; Ulys A; Jankevicius F; Jarmalaite S J Urol; 2020 Jul; 204(1):71-78. PubMed ID: 32068491 [TBL] [Abstract][Full Text] [Related]
10. ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer. Gao S; Ye H; Gerrin S; Wang H; Sharma A; Chen S; Patnaik A; Sowalsky AG; Voznesensky O; Han W; Yu Z; Mostaghel EA; Nelson PS; Taplin ME; Balk SP; Cai C Clin Cancer Res; 2016 Jul; 22(14):3672-82. PubMed ID: 26936914 [TBL] [Abstract][Full Text] [Related]
11. AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone Acetate. Todenhöfer T; Azad A; Stewart C; Gao J; Eigl BJ; Gleave ME; Joshua AM; Black PC; Chi KN J Urol; 2017 Jan; 197(1):135-142. PubMed ID: 27436429 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration-resistant prostate cancer. Chen X; Liu J; Cheng L; Li C; Zhang Z; Bai Y; Wang R; Han T; Huang C; Kong Y; Feng F; Liu X Prostate; 2020 Feb; 80(3):256-266. PubMed ID: 31856338 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of Russo JW; Gao C; Bhasin SS; Voznesensky OS; Calagua C; Arai S; Nelson PS; Montgomery B; Mostaghel EA; Corey E; Taplin ME; Ye H; Bhasin M; Balk SP Cancer Res; 2018 Nov; 78(22):6354-6362. PubMed ID: 30242112 [TBL] [Abstract][Full Text] [Related]